Facebook
Twitter
LinkedIn
ForwardTitle
Category
Credits
Event date
Cost
- 1.00 AMA PRA Category 1 Credit™
$50.00
- 1.00 AMA PRA Category 1 Credit™
$65.00
Individuals sixty-five years and older account for one-third of all prescription medications. Eighty-seven percent of the geriatric population were prescribed at least one medication, thirty-six percent were prescribed five or more medications, and thirty-eight percent also took over the counter medications. Drug misuse and abuse in the elderly can cause cognitive and physical impairment: increase risk of falls, motor vehicle accidents, and may result in a declining ability to perform activities of daily living.
- 1.00 AMA PRA Category 1 Credit™
$65.00
You might be surprised that your post-operative patients require fewer oral pain medications than you think. Many patients are first exposed to opioids in a surgical setting. A rather shocking statistic is that approximately 6% of surgical patients who are prescribed opioids become long-term users. This course will describe the benefits of reduced or eliminated opioid use post-operatively.
- 9.00 ABMS MOC II
- 9.00 AMA PRA Category 1 Credit™
$25.00
Credit PriceCME Certificate Fee: $25.00 (USD) per hr./creditOptional Maintenance of Certification Credit (MOC) Fee: $10.00 (USD) per pointsCredits Available
- 2.00 MOC
- 2.00 Approved Continuing Education (ACE)
- 2.00 AMA PRA Category 1 Credit™
- 2.00 ANCC
- 2.00 Association of Social Work Boards (ASWB)
$0.00
Widespread outbreaks of novel (new) coronavirus infection have occurred in each of the past two decades, and the current outbreak poses the third threat of a severe novel coronavirus epidemic on a global scale. In response to a 13-fold increase in the number of reported cases within the span of two weeks and active cases in more than 100 countries, the WHO reached a decision that the COVID-19 outbreak should be characterized as a pandemic.
- 0.36 AANP Contact Hours
- 0.36 AANP Pharmacology Contact Hours
- 0.50 AMA PRA Category 1 Credit™
$0.00
Agitation is among the most common behavioral symptoms in patients with dementia, including Alzheimer’s dementia. It exacts a significant burden on patients because it is associated with not only greater morbidity and mortality, but also a faster cognitive and functional decline. This activity reviews pharmacological treatment options, both a newly approved agent that is the first ever to be indicated specifically for the treatment of agitation associated with dementia due to Alzheimer’s disease and also an array of agents in development.
- 8.00 AMA PRA Category 1 Credit™
$48.00
Substance use disorders continue to be an important health issue in the United States and can lead to significant problems in all aspects of a person's life. Appropriate assessment and management of substance use is a priority in patient care. In addition, the presence of substance use disorders can complicate the treatment or management of comorbid medical conditions.
- 2.00 Approved Continuing Education (ACE)
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Association of Social Work Boards (ASWB)
- 2.00 Contact hours
$15.00
Sexual harassment in the workplace is a longstanding issue that has received renewed attention and legislation to help make the workplace safe for all. Throughout this course, information regarding what constitutes sexual harassment, how to prevent it in the workplace, employer responsibilities, employee and supervisor roles and responsibilities, and multicultural considerations will be provided. This course meets the California requirement of sexual harassment training of one hour for employees and two hours for supervisors that must be completed every two years.
- 8.00 AMA PRA Category 1 Credit™
- 8.00 ANCC
$149.00
This course meets the 8-hour training requirement for Drug Enforcement Administration (DEA) registered practitioners such as physicians, physician assistants, nurse practitioners, dentists, and others relevant to the Medication Access and Training Expansion (MATE) Act (Section 1263 of the Consolidated Appropriations Act [CAA] of 2023).